136 related articles for article (PubMed ID: 9005143)
1. Immunohistochemical detection of oestrogen receptors in ductal carcinoma in situ of the breast.
Karayiannakis AJ; Bastounis EA; Chatzigianni EB; Makri GG; Alexiou D; Karamanakos P
Eur J Surg Oncol; 1996 Dec; 22(6):578-82. PubMed ID: 9005143
[TBL] [Abstract][Full Text] [Related]
2. Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.
Poller DN; Snead DR; Roberts EC; Galea M; Bell JA; Gilmour A; Elston CW; Blamey RW; Ellis IO
Br J Cancer; 1993 Jul; 68(1):156-61. PubMed ID: 8100443
[TBL] [Abstract][Full Text] [Related]
3. Biological profile of in situ breast cancer investigated by immunohistochemical technique.
Albonico G; Querzoli P; Ferretti S; Rinaldi R; Nenci I
Cancer Detect Prev; 1998; 22(4):313-8. PubMed ID: 9674874
[TBL] [Abstract][Full Text] [Related]
4. Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast.
Gandhi A; Holland PA; Knox WF; Potten CS; Bundred NJ
Br J Cancer; 1998 Sep; 78(6):788-94. PubMed ID: 9743302
[TBL] [Abstract][Full Text] [Related]
5. Distribution of estrogen receptor in ductal carcinoma in situ of the breast.
Chaudhuri B; Crist KA; Mucci S; Malafa M; Chaudhuri PK
Surgery; 1993 Feb; 113(2):134-7. PubMed ID: 8381562
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis on biological markers in ductal carcinoma in situ of the breast.
Iwase H; Ando Y; Ichihara S; Toyoshima S; Nakamura T; Karamatsu S; Ito Y; Yamashita H; Toyama T; Omoto Y; Fujii Y; Mitsuyama S; Kobayashi S
Breast Cancer; 2001; 8(2):98-104. PubMed ID: 11342981
[TBL] [Abstract][Full Text] [Related]
7. Mean nuclear area and metallothionein expression in ductal breast tumors: correlation with estrogen receptor status.
El Sharkawy SL; Farrag AR
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):108-12. PubMed ID: 18227734
[TBL] [Abstract][Full Text] [Related]
8. Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases.
Yang M; Moriya T; Oguma M; De La Cruz C; Endoh M; Ishida T; Hirakawa H; Orita Y; Ohuchi N; Sasano H
Pathol Int; 2003 Jul; 53(7):422-8. PubMed ID: 12828606
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor immunohistochemistry in carcinoma in situ of the breast.
Bur ME; Zimarowski MJ; Schnitt SJ; Baker S; Lew R
Cancer; 1992 Mar; 69(5):1174-81. PubMed ID: 1739917
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies.
Moinfar F; Okcu M; Tsybrovskyy O; Regitnig P; Lax SF; Weybora W; Ratschek M; Tavassoli FA; Denk H
Cancer; 2003 Aug; 98(4):703-11. PubMed ID: 12910513
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast.
Luqmani YA; Campbell T; Soomro S; Shousha S; Rio MC; Coombes RC
Br J Cancer; 1993 Apr; 67(4):749-53. PubMed ID: 8385977
[TBL] [Abstract][Full Text] [Related]
12. [Steroid hormone receptors in mammary carcinoma. Immunohistochemical detection and prognostic significance].
Reiner A; Neumeister B; Reiner G; Jakesz R; Kolb R; Schemper M; Spona J
Zentralbl Pathol; 1991; 137(3):233-41. PubMed ID: 1657132
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of the erbB2 and hormone receptor status of neighboring invasive and in situ components of ductal carcinomas of the breast.
Peres RM; Serra KP; Derchain SF; Yoon JH; Pinto GA; Alvarenga M; Soares FA; Heinrich JK; da Cunha IW; Vassallo J; Sarian LO
Int J Biol Markers; 2009; 24(4):238-44. PubMed ID: 20108215
[TBL] [Abstract][Full Text] [Related]
14. Correlation of the ultrasound imaging of breast cancer and the expression of molecular biological indexes.
Xu J; Li F; Chang F
Pak J Pharm Sci; 2017 Jul; 30(4(Suppl.)):1425-1430. PubMed ID: 29043992
[TBL] [Abstract][Full Text] [Related]
15. p53 protein expression in ductal carcinoma in situ (DCIS) of the breast.
Rajan PB; Scott DJ; Perry RH; Griffith CD
Breast Cancer Res Treat; 1997 Feb; 42(3):283-90. PubMed ID: 9065612
[TBL] [Abstract][Full Text] [Related]
16. Breast carcinoma in women 35 years and younger: a pathological study.
Fernandopulle SM; Cher-Siangang P; Tan PH
Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
[TBL] [Abstract][Full Text] [Related]
17. Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast.
Holland PA; Knox WF; Potten CS; Howell A; Anderson E; Baildam AD; Bundred NJ
J Natl Cancer Inst; 1997 Jul; 89(14):1059-65. PubMed ID: 9230888
[TBL] [Abstract][Full Text] [Related]
18. Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study.
Wilbur DC; Barrows GH
Mod Pathol; 1993 Mar; 6(2):114-20. PubMed ID: 8097877
[TBL] [Abstract][Full Text] [Related]
19. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.
Tsang WY; Chan JK
Am J Surg Pathol; 1996 Aug; 20(8):921-43. PubMed ID: 8712293
[TBL] [Abstract][Full Text] [Related]
20. [ErbB-2 expression and hormone receptor status in areas of transition from in situ to invasive ductal breast carcinoma].
Peres RM; Derchain SF; Heinrich JK; Serra KP; Pinto GA; Soares FA; Sarian LO
Rev Bras Ginecol Obstet; 2009 Sep; 31(9):461-7. PubMed ID: 19876578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
